DSS receives non-compliance notice from NYSE American

DSS, Inc. announced that the company received a letter from the staff of NYSE American LLC stating that the company’s securities have been selling for a low price per share for a substantial period of time and, pursuant to Section 1003(f)(v) of the NYSE American Company Guide. The company’s continued listing is predicated on it effecting a reverse stock split of its common stock or otherwise demonstrating sustained price improvement within a reasonable period of time, which the Exchange has determined to be no later than April 20, 2024. On October 26, 2023, the company notified the Exchange that it intends to cure the stock price deficiency and to return to compliance with the Exchange continued listing standards. The company’s common stock will continue to be listed and traded on the NYSE American during this period, subject to the company’s compliance with other NYSE American continued listing standards.